BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15235190)

  • 1. Bednar tumor: a report of two cases.
    Yagi Y; Ueda K; Maruyama S; Noborio R
    J Dermatol; 2004 Jun; 31(6):484-7. PubMed ID: 15235190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of pigmented dermatofibrosarcoma protuberans (Bednar tumor).
    Akasaka T; Ohyama N; Kon S
    J Dermatol; 1997 Jun; 24(6):390-4. PubMed ID: 9241967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy.
    Elgart GW; Hanly A; Busso M; Spencer JM
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):315-7. PubMed ID: 10025857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
    Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
    Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerosing Dermatofibrosarcoma Protuberans Shows Significant Overlap With Sclerotic Fibroma in Both Routine and Immunohistochemical Analysis: A Potential Diagnostic Pitfall.
    Abdaljaleel MY; North JP
    Am J Dermatopathol; 2017 Feb; 39(2):83-88. PubMed ID: 28134725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
    Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
    Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ pigmented fibrous proliferations: the morphologic overlap between pigmented dermatofibromas and Bednar tumors.
    McAllister JC; Recht B; Hoffman TE; Sundram UN
    Am J Dermatopathol; 2008 Oct; 30(5):484-7. PubMed ID: 18806495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myxoid dermatofibroma on a great toe: a case report.
    Moon A; Yoon N; Kim HS
    Int J Clin Exp Pathol; 2015; 8(6):7605-9. PubMed ID: 26261677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.
    Lazova R; Moynes R; May D; Scott G
    Cancer; 1997 Jun; 79(11):2115-24. PubMed ID: 9179057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34-reactive myxoid dermal dendrocytoma.
    Ohata C; Kawahara K
    Am J Dermatopathol; 2002 Feb; 24(1):50-3. PubMed ID: 11803282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of Bednar tumor. Immunohistochemical positivity for CD34.
    Kobayashi T; Hasegawa Y; Konohana A; Nakamura N
    Dermatology; 1997; 195(1):57-9. PubMed ID: 9267742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It's a dermatofibroma, CD34 is irrelevant!
    Zelger B
    Am J Dermatopathol; 2002 Oct; 24(5):453-4. PubMed ID: 12357213
    [No Abstract]   [Full Text] [Related]  

  • 13. A 42-year-old woman with an abdominal mass. Dermatofibrosarcoma protuberans with focal fibrosarcomatous transformation.
    Al-Agha OM; Tabassum F
    Arch Pathol Lab Med; 2006 Jun; 130(6):882-5. PubMed ID: 16740047
    [No Abstract]   [Full Text] [Related]  

  • 14. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.
    Sadullahoğlu C; Dere Y; Atasever TR; Öztop MT; Karaaslan Ö
    Turk Patoloji Derg; 2017; 1(1):223-227. PubMed ID: 28832078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
    Goldblum JR; Tuthill RJ
    Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
    Bandarchi B; Ma L; Marginean C; Hafezi S; Zubovits J; Rasty G
    Mod Pathol; 2010 Mar; 23(3):434-8. PubMed ID: 20062007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
    Zelger BW; Ofner D; Zelger BG
    Histopathology; 1995 Jun; 26(6):519-27. PubMed ID: 7545142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A firm red-brown plaque on the arm. Dermatofibrosarcoma protuberans(DFSP), pigmented variant (Bednar tumor.
    Quigley EA; Marghoob AA; Busam KJ; Chen CS
    Arch Dermatol; 2009 May; 145(5):589-94. PubMed ID: 19451510
    [No Abstract]   [Full Text] [Related]  

  • 19. Pigmented dermatofibrosarcoma protuberans with prominent meningothelial-like whorls.
    Wang J; Yang W
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():65-9. PubMed ID: 18544057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When Immunohistochemistry Deceives Us: The Pitfalls of CD34 and Factor XIIIa Stains in Dermatofibroma and Dermatofibrosarcoma Protuberans.
    John AM; Holahan HH; Singh P; Handler MZ; Lambert WC
    Skinmed; 2017; 15(1):53-55. PubMed ID: 28270311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.